SEVERE COMBINED IMMUNODEFICIENCY (SCID)
Clinical trials for SEVERE COMBINED IMMUNODEFICIENCY (SCID) explained in plain language.
Never miss a new study
Get alerted when new SEVERE COMBINED IMMUNODEFICIENCY (SCID) trials appear
Sign up with your email to follow new studies for SEVERE COMBINED IMMUNODEFICIENCY (SCID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double transplant offers hope for kids with rare immune diseases
Disease control ENROLLING_BY_INVITATIONThis study tests a new approach for people aged 5 to 45 with primary immune disorders and severe lung damage. Participants receive a double lung transplant followed by a stem cell transplant from the same donor. The goal is to see if this combination is safe and can help the body…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY (SCID)
Phase: PHASE1, PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Gene therapy survivors monitored for decades in landmark study
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 70 people who previously received gene therapy for a rare immune disorder called ADA-SCID. Researchers want to see how well the treatment worked over time and check for any long-term side effects. No new treatment is given in this study—it only collects i…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY (SCID)
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 17, 2026 08:14 UTC